Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
<h4>Background</h4>In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circul...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0242124 |
id |
doaj-c575d4a26fbf489abf178463a6b14172 |
---|---|
record_format |
Article |
spelling |
doaj-c575d4a26fbf489abf178463a6b141722021-03-04T11:52:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011511e024212410.1371/journal.pone.0242124Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.Wemboo Afiwa HalatokoYao Rodion KonuFifonsi Adjidossi Gbeasor-KomlanviArnold Junior SadioMartin Kouame TchankoniKoffi Segbeaya KomlanviMounerou SalouAmeyo Monique DorkenooIssaka MamanAmétépé AgbobliMajesté Ihou WatebaKomi Séraphin AdjohEdem Goeh-AkueYem-Bla KaoInnocent KpetoPaul PanaRebecca Kinde-SossouAgbeko TamekloeJosée Nayo-ApétsianyiSimon-Pierre Hamadi AssaneMireille Prine-DavidSossinou Marcel AwoussiMohaman DjibrilMoustafa MijiyawaAnoumou Claver DagnraDidier Koumavi Ekouevi<h4>Background</h4>In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country.<h4>Objective</h4>This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé.<h4>Materials and methods</h4>From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests.<h4>Results</h4>A total of 955 participants with a median age of 36 (IQR 32-43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9-2.6%.<h4>Conclusion</h4>The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.https://doi.org/10.1371/journal.pone.0242124 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wemboo Afiwa Halatoko Yao Rodion Konu Fifonsi Adjidossi Gbeasor-Komlanvi Arnold Junior Sadio Martin Kouame Tchankoni Koffi Segbeaya Komlanvi Mounerou Salou Ameyo Monique Dorkenoo Issaka Maman Amétépé Agbobli Majesté Ihou Wateba Komi Séraphin Adjoh Edem Goeh-Akue Yem-Bla Kao Innocent Kpeto Paul Pana Rebecca Kinde-Sossou Agbeko Tamekloe Josée Nayo-Apétsianyi Simon-Pierre Hamadi Assane Mireille Prine-David Sossinou Marcel Awoussi Mohaman Djibril Moustafa Mijiyawa Anoumou Claver Dagnra Didier Koumavi Ekouevi |
spellingShingle |
Wemboo Afiwa Halatoko Yao Rodion Konu Fifonsi Adjidossi Gbeasor-Komlanvi Arnold Junior Sadio Martin Kouame Tchankoni Koffi Segbeaya Komlanvi Mounerou Salou Ameyo Monique Dorkenoo Issaka Maman Amétépé Agbobli Majesté Ihou Wateba Komi Séraphin Adjoh Edem Goeh-Akue Yem-Bla Kao Innocent Kpeto Paul Pana Rebecca Kinde-Sossou Agbeko Tamekloe Josée Nayo-Apétsianyi Simon-Pierre Hamadi Assane Mireille Prine-David Sossinou Marcel Awoussi Mohaman Djibril Moustafa Mijiyawa Anoumou Claver Dagnra Didier Koumavi Ekouevi Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020. PLoS ONE |
author_facet |
Wemboo Afiwa Halatoko Yao Rodion Konu Fifonsi Adjidossi Gbeasor-Komlanvi Arnold Junior Sadio Martin Kouame Tchankoni Koffi Segbeaya Komlanvi Mounerou Salou Ameyo Monique Dorkenoo Issaka Maman Amétépé Agbobli Majesté Ihou Wateba Komi Séraphin Adjoh Edem Goeh-Akue Yem-Bla Kao Innocent Kpeto Paul Pana Rebecca Kinde-Sossou Agbeko Tamekloe Josée Nayo-Apétsianyi Simon-Pierre Hamadi Assane Mireille Prine-David Sossinou Marcel Awoussi Mohaman Djibril Moustafa Mijiyawa Anoumou Claver Dagnra Didier Koumavi Ekouevi |
author_sort |
Wemboo Afiwa Halatoko |
title |
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020. |
title_short |
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020. |
title_full |
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020. |
title_fullStr |
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020. |
title_full_unstemmed |
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020. |
title_sort |
prevalence of sars-cov-2 among high-risk populations in lomé (togo) in 2020. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2020-01-01 |
description |
<h4>Background</h4>In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country.<h4>Objective</h4>This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé.<h4>Materials and methods</h4>From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests.<h4>Results</h4>A total of 955 participants with a median age of 36 (IQR 32-43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9-2.6%.<h4>Conclusion</h4>The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening. |
url |
https://doi.org/10.1371/journal.pone.0242124 |
work_keys_str_mv |
AT wembooafiwahalatoko prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT yaorodionkonu prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT fifonsiadjidossigbeasorkomlanvi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT arnoldjuniorsadio prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT martinkouametchankoni prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT koffisegbeayakomlanvi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT mounerousalou prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT ameyomoniquedorkenoo prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT issakamaman prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT ametepeagbobli prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT majesteihouwateba prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT komiseraphinadjoh prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT edemgoehakue prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT yemblakao prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT innocentkpeto prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT paulpana prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT rebeccakindesossou prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT agbekotamekloe prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT joseenayoapetsianyi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT simonpierrehamadiassane prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT mireilleprinedavid prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT sossinoumarcelawoussi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT mohamandjibril prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT moustafamijiyawa prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT anoumouclaverdagnra prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT didierkoumaviekouevi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 |
_version_ |
1714803370480369664 |